World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
36808
World Ranking
17359
National Ranking
1569

Overview

John Yarnold is affiliated with the Institute of Cancer Research in the United Kingdom and has a substantial research presence in the fields of medicine and biochemistry, genetics, and molecular biology. Their work prominently addresses cancer research, with a strong emphasis on radiation and oncology-related studies.

The scientist's research spans several subfields, including:

  • Cancer Research
  • Radiology, Nuclear Medicine and Imaging
  • Radiation
  • Pulmonary and Respiratory Medicine
  • Oncology

John Yarnold's main topics of research include:

  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Advances in Oncology and Radiotherapy
  • Effects of Radiation Exposure
  • Breast Lesions and Carcinomas
  • Cancer, Hypoxia, and Metabolism
  • Nanoplatforms for cancer theranostics

Their publications have appeared frequently in the following venues:

  • Radiotherapy and Oncology
  • The Lancet
  • Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • SSRN Electronic Journal

Among recent papers, John Yarnold is associated with notable works such as:

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial (2020), published in The Lancet
  • Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer (2020), published in Journal of Clinical Oncology
  • Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial (2023), published in The Lancet
  • Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial (2020), published in International Journal of Radiation Oncology*Biology*Physics
  • How Low Can You Go? The Radiobiology of Hypofractionation (2022), published in Clinical Oncology

Frequent co-authorship is an important aspect of John Yarnold's research, collaborating multiple times with the following colleagues:

  • Joanne Haviland
  • Anna M. Kirby
  • Navita Somaiah
  • Judith M. Bliss
  • Adrian Murray Brunt

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

    Joanne S Haviland;Joanne S Haviland;J Roger Owen;John A Dewar;Rajiv K Agrawal

  • The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

    David P Dearnaley;Vincent S Khoo;Andrew R Norman;Lesley Meyer

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

    Adrian Murray Brunt;Adrian Murray Brunt;Joanne S Haviland;Duncan A Wheatley;Mark A Sydenham

  • Pathogenetic mechanisms in radiation fibrosis.

    John Yarnold;Marie-Catherine Vozenin Brotons;Marie-Catherine Vozenin Brotons

  • Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

    J Roger Owen;Anita Ashton;Judith M Bliss;Janis Homewood

  • Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial

    John Yarnold;Anita Ashton;Judith M Bliss;Janis Homewood

  • Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

    Charlotte E Coles;Clare L Griffin;Anna M Kirby;Jenny Titley

  • aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

    R G Gray;D Rea;K Handley;S J Bowden

  • Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

    P. Price;P.J. Hoskin;D. Easton;D. Austin

  • ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

    Birgitte V. Offersen;Liesbeth J. Boersma;Carine Kirkove;Sandra Hol

  • Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy

    Ellen Donovan;Natalie Bleakley;Erica Denholm;Phil Evans

  • Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

    A Gregor;A Cull;R J Stephens;J A Kirkpatrick

  • The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity

    A.M. Moody;W.P.M. Mayles;J.M. Bliss;R.P. A'Hern

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

    P.J. Hoskin;P. Price;D. Easton;J. Regan

  • Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

    Penelope Hopwood;Joanne S Haviland;Georges Sumo;Judith Mills

  • ESTABLISHMENT OF A RADIOGENOMICS CONSORTIUM

    Catharine West;Barry S. Rosenstein

  • First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

    Rajiv K Agrawal;Abdulla Alhasso;Peter J Barrett-Lee

Frequent Co-Authors

Judith M. Bliss
Judith M. Bliss Institute of Cancer Research
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Peter Hoskin
Peter Hoskin University of Manchester
Alison M. Dunning
Alison M. Dunning University of Cambridge
Robert E. Coleman
Robert E. Coleman University of Sheffield
Roger A'Hern
Roger A'Hern Royal Marsden NHS Foundation Trust
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Philip Poortmans
Philip Poortmans University of Antwerp
Catharine M L West
Catharine M L West University of Manchester
Andrew Tutt
Andrew Tutt Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in building a medical career beyond the traditional MD, a number of flexible online options are available. Many students are exploring the shortest dnp programs online to quickly advance into leadership or specialized nursing roles, often while continuing to work. These programs can shave months or even years off the time to a doctorate in nursing practice.

Flexibility is a major benefit—students can choose among various dnp programs online that fit their schedules and learning needs. For those looking to start their healthcare career as soon as possible, fast track lpn options can provide a quick pathway into practical nursing and entry-level care positions.

If your interest lies in mental health, several online msn pmhnp programs allow you to train as a Psychiatric Mental Health Nurse Practitioner on an accelerated timeline. Whether you aim to lead, specialize, or start your healthcare career fast, there’s an online pathway to match your goals.

Best Scientists Citing John Yarnold

Trending Scientists

Recently Published Articles